We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$207M
AUM Growth
+$72.1M
Cap. Flow
+$59.3M
Cap. Flow %
28.65%
Top 10 Hldgs %
47.42%
Holding
159
New
12
Increased
64
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$6.79M
2
WPZ
Williams Partners L.P.
WPZ
+$5.53M
3
BPL
Buckeye Partners, L.P.
BPL
+$5M
4
ET icon
Energy Transfer Partners
ET
+$3.75M
5
EPD icon
Enterprise Products Partners
EPD
+$3.26M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.42M
2
MDVN
MEDIVATION, INC.
MDVN
+$546K
3
RLYP
RELYPSA INC COM
RLYP
+$521K
4
TRGP icon
Targa Resources
TRGP
+$430K
5
USO icon
United States Oil Fund
USO
+$16K

Sector Composition

Rank Sector Weight
1 Energy 63.86%
2 Healthcare 21.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
101
ImmunityBio
IBRX
$7.44B
$295K 0.14%
37,895
– –
AIMT
102
DELISTED
Aimmune Therapeutics
AIMT
$293K 0.14%
19,501
– –
MGNX icon
103
MacroGenics
MGNX
$235M
$292K 0.14%
9,762
– –
RARE icon
104
Ultragenyx Pharmaceutical
RARE
$2.65B
$287K 0.14%
4,050
– –
ALDR
105
DELISTED
Alder Biopharmaceuticals
ALDR
$281K 0.14%
8,582
– –
RXDX
106
DELISTED
Ignyta, Inc.
RXDX
$281K 0.14%
44,599
– –
ALNY icon
107
Alnylam Pharmaceuticals
ALNY
$36.3B
$276K 0.13%
4,078
– –
TGTX icon
108
TG Therapeutics
TGTX
$8.58B
$273K 0.13%
35,297
– –
KITE
109
DELISTED
Kite Pharma, Inc.
KITE
$273K 0.13%
4,889
– –
ATRA icon
110
Atara Biotherapeutics
ATRA
$71.2M
$271K 0.13%
506
– –
CYTK icon
111
Cytokinetics
CYTK
$11B
$270K 0.13%
29,379
– –
NBIX icon
112
Neurocrine Biosciences
NBIX
$17.7B
$270K 0.13%
5,324
– –
GBT
113
DELISTED
Global Blood Therapeutics, Inc.
GBT
$270K 0.13%
11,710
– –
IOVA icon
114
Iovance Biotherapeutics
IOVA
$2.23B
$269K 0.13%
32,726
– –
AGIO icon
115
Agios Pharmaceuticals
AGIO
$2.16B
$268K 0.13%
5,068
– –
AKBA icon
116
Akebia Therapeutics
AKBA
$327M
$268K 0.13%
29,590
– –
LOXO
117
DELISTED
Loxo Oncology, Inc
LOXO
$268K 0.13%
10,231
– –
SIOX
118
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$267K 0.13%
2,383
– –
IMMU
119
DELISTED
Immunomedics Inc
IMMU
$263K 0.13%
81,010
– –
KDNY
120
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$261K 0.13%
4,202
– –
TRVN
121
DELISTED
Trevena, Inc.
TRVN
$259K 0.13%
61
– –
ONC
122
BeOne Medicines Ltd
ONC
$33.8B
$257K 0.12%
8,344
– –
SPY icon
123
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$250K 0.12%
+200
New +$43.2K
XLRN
124
DELISTED
Acceleron Pharma
XLRN
$250K 0.12%
6,910
– –
AVXS
125
DELISTED
AveXis, Inc. Common Stock
AVXS
$242K 0.12%
5,869
– –
3 4
5
6 7

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Virtus ETF Advisers held 159 positions worth $207M, up 53% from $135M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Virtus ETF Advisers deployed $59.3M of net new capital in Q3 2016, opening 12 new positions and adding to 64 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, down from 64% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $4.42M trimmed.

  • Virtus ETF Advisers's largest Q3 2016 buy was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q3 2016, an estimated $6.79M increase.
  • Virtus ETF Advisers's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $4.42M.
  • Virtus ETF Advisers fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $546K.
  • Virtus ETF Advisers's ten largest holdings make up 47% of its $207M portfolio in Q3 2016.
  • Virtus ETF Advisers opened 12 new positions and closed 5 in Q3 2016.
  • Virtus ETF Advisers's portfolio value rose 53% quarter-over-quarter to $207M.

Based on Virtus ETF Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.